Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.

scientific article

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1538-7836.2011.04240.X
P698PubMed publication ID21324057
P5875ResearchGate publication ID49838740

P50authorGrégoire Le GalQ74180627
P2093author name stringR H White
P S Wells
S Solymoss
M J Kovacs
M Righini
M Carrier
M Crowther
D A Anderson
S R Kahn
M Rodger
A Delluc
I Chagnon
M T Betancourt
L Vickars
P2860cites workLong-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismQ34179254
Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortalityQ36534259
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyQ36841584
Venous thromboembolism: risk factors for recurrenceQ37396634
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolismQ37741638
Validation of a diagnostic approach to exclude recurrent venous thromboembolism.Q38383599
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial InvestigatorsQ43681404
Extended oral anticoagulant therapy after a first episode of pulmonary embolism.Q44496670
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismQ44548746
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factorQ44852505
Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawalQ46808776
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismQ49171054
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.Q51831890
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea.Q53536463
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong studyQ56989052
P433issue6
P921main subjectthromboembolismQ891391
P304page(s)1126-1132
P577publication date2011-06-01
P1433published inJournal of Thrombosis and HaemostasisQ6296004
P1476titleResidual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study
P478volume9

Reverse relations

cites work (P2860)
Q37368820A systematic review of the utility of residual vein obstruction studies in primary and secondary venous thrombosis
Q34254243Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.
Q41667853Epidemiology of venous thromboembolism
Q34264218Epidemiology, risk factors and sequelae of venous thromboembolism
Q38088606Postintervention duration of anticoagulation in venous surgery
Q37864726RVO--real value obscure
Q59804033Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data
Q36201247Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Q28067893The epidemiology of venous thromboembolism

Search more.